US FDA gives green light for $2.1m treatment of spinal muscular atrophy

OxyContin maker has been accused of playing a key role in fuelling the US opioid crisis

Investors back Schrödinger’s plan to develop its own drugs

Shares of Teva and others fall after 44 states accuse them of an anti-competitive conspiracy

Trump administration attempts to pressure pharmaceutical companies into lowering prices

Offering is the largest bond issue of 2019 so far

CEO has previously cited ‘moral requirement’ to charge as much as possible

Company hit by a $2.5bn charge related to clinical failure of antidepressant

US expected to redouble efforts to pursue criminal prosecutions while others chase civil claims

John Kapoor and 4 others found guilty of scheme to boost sales of highly addictive painkiller

Schultz likens claims against drugmakers to blaming drunk driving on makers of alcoholic drinks

Insitro is attempting to create an equal partnership between the life sciences and computer sciences

Pfizer, Eli Lilly and Merck raise earnings forecasts for 2019

US pharmaceutical company reported better than expected sales and earnings

Animal health spin off helps pharmaceutical group raise earnings forecasts

The US pharmaceutical company beat expectations on earnings and revenue in the first quarter

Blockbuster drug’s revenue outside US takes hit from new competition

Drug company’s chief Michel Vounatsos says it has the cash for share buybacks and M&A

Walgreens and Rite Aid respond to pressure from regulator over youth tobacco use

World’s largest healthcare group lifts guidance despite litigation worries

Opioid maker sought drug group that treats abuse of its own painkillers

False rumours and anti-government sentiment spur resurgence of infectious disease

US group seeks regulatory approval for first ‘game-changing’ product in two decades

Consumer goods giant sheds £3bn in market value over potential exposure to opioid charges

UK-listed drugmaker vows to contest allegations as shares fall more than 70%